Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells

P. G. Natali, P. Giacomini, A. Bigotti, K. Imai, M. R. Nicotra, A. K. Ng, S. Ferrone

Research output: Contribution to journalArticle

Abstract

Surgically removed normal and malignant mammary tissues and human breast carcinoma cell lines were tested in binding assays with monoclonal antibodies to HLA-A,B,C antigens, β 2-microglobulin, HLA-DR antigens, and tumor-associated antigens; the latter included a Mr 280,000, a Mr 94,000, and a Mr 85,000 membrane-bound glycoprotein and a cytoplasmic antigen. HLA-A,B antigens, β 2-microglobulin, HLA-DR antigens, and the cytoplasmic antigen are expressed by normal mammary cells. Their malignant transformation may be associated with quantitative changes in the expression of these antigens and with the appearance of Mr 94,000 and Mr 85,000 glycoproteins. The Mr 280,000 glycoprotein was detected on only one of the breast carcinoma cell lines tested. Analysis of primary tumors and autologous axillary lymph node metastasis from 13 patients has shown differences in the expression of all the antigens tested between primary and metastatic lesions.

Original languageEnglish
Pages (from-to)660-668
Number of pages9
JournalCancer Research
Volume43
Issue number2
Publication statusPublished - 1983

Fingerprint

Neoplasm Antigens
Breast Neoplasms
Antigens
HLA-A Antigens
HLA-B Antigens
HLA-DR Antigens
Glycoproteins
Breast
Cell Line
Membrane Glycoproteins
Lymph Nodes
Monoclonal Antibodies
Neoplasm Metastasis
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Natali, P. G., Giacomini, P., Bigotti, A., Imai, K., Nicotra, M. R., Ng, A. K., & Ferrone, S. (1983). Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells. Cancer Research, 43(2), 660-668.

Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells. / Natali, P. G.; Giacomini, P.; Bigotti, A.; Imai, K.; Nicotra, M. R.; Ng, A. K.; Ferrone, S.

In: Cancer Research, Vol. 43, No. 2, 1983, p. 660-668.

Research output: Contribution to journalArticle

Natali, PG, Giacomini, P, Bigotti, A, Imai, K, Nicotra, MR, Ng, AK & Ferrone, S 1983, 'Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells', Cancer Research, vol. 43, no. 2, pp. 660-668.
Natali, P. G. ; Giacomini, P. ; Bigotti, A. ; Imai, K. ; Nicotra, M. R. ; Ng, A. K. ; Ferrone, S. / Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells. In: Cancer Research. 1983 ; Vol. 43, No. 2. pp. 660-668.
@article{b1967e2dca9c4ba5902eb5bcc7024ea8,
title = "Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells",
abstract = "Surgically removed normal and malignant mammary tissues and human breast carcinoma cell lines were tested in binding assays with monoclonal antibodies to HLA-A,B,C antigens, β 2-microglobulin, HLA-DR antigens, and tumor-associated antigens; the latter included a Mr 280,000, a Mr 94,000, and a Mr 85,000 membrane-bound glycoprotein and a cytoplasmic antigen. HLA-A,B antigens, β 2-microglobulin, HLA-DR antigens, and the cytoplasmic antigen are expressed by normal mammary cells. Their malignant transformation may be associated with quantitative changes in the expression of these antigens and with the appearance of Mr 94,000 and Mr 85,000 glycoproteins. The Mr 280,000 glycoprotein was detected on only one of the breast carcinoma cell lines tested. Analysis of primary tumors and autologous axillary lymph node metastasis from 13 patients has shown differences in the expression of all the antigens tested between primary and metastatic lesions.",
author = "Natali, {P. G.} and P. Giacomini and A. Bigotti and K. Imai and Nicotra, {M. R.} and Ng, {A. K.} and S. Ferrone",
year = "1983",
language = "English",
volume = "43",
pages = "660--668",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "2",

}

TY - JOUR

T1 - Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells

AU - Natali, P. G.

AU - Giacomini, P.

AU - Bigotti, A.

AU - Imai, K.

AU - Nicotra, M. R.

AU - Ng, A. K.

AU - Ferrone, S.

PY - 1983

Y1 - 1983

N2 - Surgically removed normal and malignant mammary tissues and human breast carcinoma cell lines were tested in binding assays with monoclonal antibodies to HLA-A,B,C antigens, β 2-microglobulin, HLA-DR antigens, and tumor-associated antigens; the latter included a Mr 280,000, a Mr 94,000, and a Mr 85,000 membrane-bound glycoprotein and a cytoplasmic antigen. HLA-A,B antigens, β 2-microglobulin, HLA-DR antigens, and the cytoplasmic antigen are expressed by normal mammary cells. Their malignant transformation may be associated with quantitative changes in the expression of these antigens and with the appearance of Mr 94,000 and Mr 85,000 glycoproteins. The Mr 280,000 glycoprotein was detected on only one of the breast carcinoma cell lines tested. Analysis of primary tumors and autologous axillary lymph node metastasis from 13 patients has shown differences in the expression of all the antigens tested between primary and metastatic lesions.

AB - Surgically removed normal and malignant mammary tissues and human breast carcinoma cell lines were tested in binding assays with monoclonal antibodies to HLA-A,B,C antigens, β 2-microglobulin, HLA-DR antigens, and tumor-associated antigens; the latter included a Mr 280,000, a Mr 94,000, and a Mr 85,000 membrane-bound glycoprotein and a cytoplasmic antigen. HLA-A,B antigens, β 2-microglobulin, HLA-DR antigens, and the cytoplasmic antigen are expressed by normal mammary cells. Their malignant transformation may be associated with quantitative changes in the expression of these antigens and with the appearance of Mr 94,000 and Mr 85,000 glycoproteins. The Mr 280,000 glycoprotein was detected on only one of the breast carcinoma cell lines tested. Analysis of primary tumors and autologous axillary lymph node metastasis from 13 patients has shown differences in the expression of all the antigens tested between primary and metastatic lesions.

UR - http://www.scopus.com/inward/record.url?scp=0020665445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020665445&partnerID=8YFLogxK

M3 - Article

C2 - 6336658

AN - SCOPUS:0020665445

VL - 43

SP - 660

EP - 668

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 2

ER -